|
Oxford BioDynamics PLC on Friday said it raised £543,577 after completing its PrimaryBid offer announced on Tuesday. The Oxford-based biotechnology firm focused on discovering and developing epigenetic biomarkers said retail investors subscribed for a total of 4.9 million new shares at the issue price of 11 pence each. Shares in Oxford BioDynamics were down 2.7% to 11.00 pence each in London on Friday afternoon. PrimaryBid offer subscribers included Chief Scientific Officer Alexandre Akoulitchev for 300,000 shares, Oxford BioDynamics explained, alongside Chief Financial Officer Paul Stockdale subscribing for 90,909 shares. Oxford BioDynamics said this followed raising £5.6 million via the placing of 48.1 million new shares and 2.5 million subscription shares at the same issue price. This means a total of £6.1 million has been raised across all equity raises via the issue of 55.6 million shares, around 28% of total Oxford BioDynamics shares. The PrimaryBid offer shares are expected to be admitted for trading on AIM in London on August 22, while the placing and subscription shares are expected to be admitted a day earlier. Copyright 2023 Alliance News Ltd. All Rights Reserved.
|
